Boston Partners - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Boston Partners ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,088,000
-7.5%
112,143
-2.7%
0.00%0.0%
Q2 2018$1,176,000
-32.3%
115,282
-13.8%
0.00%
-50.0%
Q1 2018$1,738,000
-27.4%
133,6820.0%0.00%
-33.3%
Q4 2017$2,393,000
-28.7%
133,6820.0%0.00%
-25.0%
Q3 2017$3,355,000
+4.1%
133,6820.0%0.00%0.0%
Q2 2017$3,222,000
+6.7%
133,682
-14.8%
0.00%0.0%
Q1 2017$3,020,000
+25.0%
156,8580.0%0.00%
+33.3%
Q4 2016$2,416,000156,8580.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$16,279,0002.44%
Abingworth LLP 1,041,131$6,517,0002.23%
Telemetry Investments, L.L.C. 194,789$1,219,0002.06%
AIGH Capital Management LLC 749,608$4,692,0001.91%
Trellus Management Company, LLC 340,000$2,128,0001.76%
Bruce & Co., Inc. 929,312$5,817,0001.12%
Worth Venture Partners, LLC 191,093$1,196,0000.95%
GENERAL AMERICAN INVESTORS CO INC 1,000,751$6,265,0000.62%
Weil Company, Inc. 104,907$657,0000.39%
NEXPOINT ASSET MANAGEMENT, L.P. 140,020$877,0000.29%
View complete list of PARATEK PHARMACEUTICALS INC shareholders